REQUEST A DEMO
Total
USD $0.00
Search more companies

Sunley Pharma Sdn. Bhd. (Malaysia)

Main Activities: Pharmacies and Drug Stores
Full name: Sunley Pharma Sdn. Bhd. Profile Updated: August 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Sunley Pharma Sdn. Bhd. is based in Malaysia, with the head office in Kuala Lumpur. It operates in the Pharmacies and Drug Stores sector. The company was established on January 27, 2021. From the latest financial highlights, Sunley Pharma Sdn. Bhd. reported a net sales revenue drop of 38.89% in 2023. Over the same period, its total assets grew by 66.61%. In 2023, Sunley Pharma Sdn. Bhd.’s net profit margin increased by 0.43%.

Headquarters
82-3, Jalan Jalil 1, Bumi Bukit Jalil, Lebuhraya Puchong-Sungai Besi
Kuala Lumpur; Federal Territories; Postal Code: 57000

Contact Details: Purchase the Sunley Pharma Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Sunley Pharma Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Sunley Pharma Sdn. Bhd. report to view the information.
Incorporation Date:
January 27, 2021
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Sunley Pharma Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
-38.89%
Total operating revenue
-38.89%
Operating profit (EBIT)
-19.4%
Net Profit (Loss) for the Period
-19.72%
Total assets
66.61%
Total equity
66.46%
Operating Profit Margin (ROS)
0.53%
Net Profit Margin
0.43%
Return on Equity (ROE)
-42.86%
Quick Ratio
-0.12%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?